San Antonio Breast Cancer Symposium: What’s New This Year?
SABCS co-chair and AACR President Carlos L. Arteaga, MD, shares his views on this year's symposium and what the...
Author:
Srivani Ravoori, PhD
SABCS co-chair and AACR President Carlos L. Arteaga, MD, shares his views on this year's symposium and what the...
The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses...
A new study shows big data can be exploited to develop effective breast cancer prevention strategies and the NIH...
A nine-valent HPV vaccine currently under FDA review may prevent nearly 90 percent of cervical cancers worldwide, but we...
If you are someone who would bet all your chips on helping people not get cancer in the first...
In a study published Tuesday in the American Association for Cancer Research’s journal Clinical Cancer Research, researchers identified two...
When Bayer first introduced aspirin in 1899, the expectation from the drug was simple: alleviate headache, pain, and fever....
For decades, experimental cancer drugs that did not provide measurable benefit to a significant number of patients in a...